164 related articles for article (PubMed ID: 1551347)
1. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus.
Collen MJ; Johnson DA
Dig Dis Sci; 1992 Apr; 37(4):570-6. PubMed ID: 1551347
[TBL] [Abstract][Full Text] [Related]
2. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy.
Collen MJ; Johnson DA; Sheridan MJ
Dig Dis Sci; 1994 Feb; 39(2):410-7. PubMed ID: 8313826
[TBL] [Abstract][Full Text] [Related]
3. Gastric acid hypersecretion in refractory gastroesophageal reflux disease.
Collen MJ; Lewis JH; Benjamin SB
Gastroenterology; 1990 Mar; 98(3):654-61. PubMed ID: 2298369
[TBL] [Abstract][Full Text] [Related]
4. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
Collen MJ; Strong RM
Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
[TBL] [Abstract][Full Text] [Related]
5. Bleeding duodenal ulcer. Role of gastric acid hypersecretion.
Collen MJ; Kalloo AN; Sheridan MJ
Dig Dis Sci; 1993 Feb; 38(2):269-75. PubMed ID: 8093870
[TBL] [Abstract][Full Text] [Related]
6. Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls.
Hirschowitz BI
Dig Dis Sci; 1996 Jul; 41(7):1384-91. PubMed ID: 8689915
[TBL] [Abstract][Full Text] [Related]
7. A new physiologic approach for the surgical treatment of patients with Barrett's esophagus: technical considerations and results in 65 patients.
Csendes A; Braghetto I; Burdiles P; Díaz JC; Maluenda F; Korn O
Ann Surg; 1997 Aug; 226(2):123-33. PubMed ID: 9296504
[TBL] [Abstract][Full Text] [Related]
8. Maximal acid reflux control for Barrett's oesophagus: feasible and effective.
Srinivasan R; Katz PO; Ramakrishnan A; Katzka DA; Vela MF; Castell DO
Aliment Pharmacol Ther; 2001 Apr; 15(4):519-24. PubMed ID: 11284781
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
Jankowski J; Hopwood D; Pringle R; Wormsley KG
Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine therapy in patients with idiopathic gastric acid hypersecretion. A prospective study.
Collen MJ; Wirshup JF
Dig Dis Sci; 1995 Aug; 40(8):1687-90. PubMed ID: 7648968
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy.
Collen MJ; Abdulian JD; Chen YK
Am J Gastroenterol; 1995 Jul; 90(7):1053-7. PubMed ID: 7611195
[TBL] [Abstract][Full Text] [Related]
12. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
Menges M; Müller M; Zeitz M
Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
[TBL] [Abstract][Full Text] [Related]
13. Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole.
Lee FI; Isaacs PE
Am J Gastroenterol; 1988 Sep; 83(9):914-6. PubMed ID: 3414644
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.
Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T
Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656
[TBL] [Abstract][Full Text] [Related]
15. Time pattern of gastric acidity in Barrett's esophagus.
Savarino V; Mela GS; Zentilin P; Mele MR; Mansi C; Remagnino AC; Vigneri S; Malesci A; Belicchi M; Lapertosa G; Celle G
Dig Dis Sci; 1996 Jul; 41(7):1379-83. PubMed ID: 8689914
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Barrett's esophagus with H2 blockers.
Cooper BT; Barbezat GO
J Clin Gastroenterol; 1987 Apr; 9(2):139-41. PubMed ID: 2883213
[TBL] [Abstract][Full Text] [Related]
17. Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.
Sontag SJ; Schnell TG; Chejfec G; Kurucar C; Karpf J; Levine G
Aliment Pharmacol Ther; 1997 Feb; 11(1):147-56. PubMed ID: 9042987
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.
Peters FT; Ganesh S; Kuipers EJ; Sluiter WJ; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH
Gut; 1999 Oct; 45(4):489-94. PubMed ID: 10486353
[TBL] [Abstract][Full Text] [Related]
19. Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium.
Tharalson EF; Martinez SD; Garewal HS; Sampliner RE; Cui H; Pulliam G; Fass R
Am J Gastroenterol; 2002 Apr; 97(4):851-6. PubMed ID: 12003418
[TBL] [Abstract][Full Text] [Related]
20. Definition for idiopathic gastric acid hypersecretion. A statistical and functional evaluation.
Collen MJ; Sheridan MJ
Dig Dis Sci; 1991 Oct; 36(10):1371-6. PubMed ID: 1914757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
